Concepedia

Gavin Worth

GW

Statistics

Publications

4

Citations

74

H-Index

4

Active since

2015

Affiliations

Amgen (Switzerland)(Current)

Amgen (United States)

Amgen (Germany)

Amgen (United Kingdom)

Gavin Worth is an author at Amgen (Switzerland) specializing in medicine, health economics, and pharmacoeconomics.

Publications per year

2015–2022

4

Publications

4

Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis

Evan Davies, Louis S. Matza, Gavin Worth et al. · Health and Quality of Life Outcomes · 2015 · 37 citations · Full text

, , +13

Real-world treatment patterns of PCSK9 inhibitors among patients with dyslipidemia in Germany, Spain, and the United Kingdom

Ming‐Hui Tai, Jason F. Shepherd, Hollie Bailey et al. · Current Medical Research and Opinion · 2018 · 14 citations

, , +15

Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis

Wolfgang Böcker, Indraraj Umesh Doobaree, Artak Khachatryan et al. · Osteoporosis International · 2021 · 13 citations

, , +12

Exploring the treatment gap among patients with osteoporosis-related fractures in France

Patrice Fardellone, Lianne Barnieh, Nadia Quignot et al. · Archives of Osteoporosis · 2022 · 10 citations

, , +14

1–4 of 4